Dr Candace S Lapidus, MD | |
5 Spinnaker Dr, Barrington, RI 02806-2831 | |
(401) 499-4999 | |
Not Available |
Full Name | Dr Candace S Lapidus |
---|---|
Gender | Female |
Speciality | Dermatology |
Location | 5 Spinnaker Dr, Barrington, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457364382 | NPI | - | NPPES |
709004108 | Other | RI | GROUP MEDICARE |
CL30881 | Medicaid | RI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 10201 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Candace S Lapidus, MD Po Box 247, Barrington, RI 02806-0247 Ph: (401) 499-4999 | Dr Candace S Lapidus, MD 5 Spinnaker Dr, Barrington, RI 02806-2831 Ph: (401) 499-4999 |
News Archive
More than 26 million patients worldwide suffer from heart failure every year, according to the European Heart Failure Association. A disorder often associated with a bad diagnosis, with the consequent increase in mortality and morbidity, and frequent re-hospitalizations, which are a great problem for patients and their families, as well as a great economic burden for the healthcare system.
Researchers have identified another good reason to eat more mushrooms. New research , published in Food Science & Nutrition (January 2021) found that adding a mushroom serving to the diet increased the intake of several micronutrients, including shortfall nutrients such as vitamin D, without any increase in calories, sodium or fat.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today the presentation of new preclinical data for CYC065, a novel, orally-available, cell cycle kinase inhibitor. The data were reported at a poster presentation at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
German researchers have found a significant association of IL28B genotypes to interferon-based antiviral treatment outcome, and to graft inflammation caused by hepatitis C virus (HCV). The study determined that the presence of G-allele serves as a marker for severe HCV-induced graft inflammation, as well as a predictor for unsuccessful treatment.
› Verified 3 days ago